Posted February 14, 2018 07:27:03 A new blood test is in the works to fight cancer, but it could also give the wrong results if it’s taken incorrectly, according to a new report.
The research, published in the journal PLOS ONE, examined how a new blood-test can be used to identify certain types of cancer in people who already have a genetic mutation known as a COVID-19 gene mutation.
The researchers found that when a blood test was used correctly, the new blood product could tell if a person has the mutated gene.
While some blood tests can be inaccurate in certain instances, it’s difficult to pinpoint exactly what could be causing a problem.
A new test could be used in Arkansas to detect certain types to fight COVID in the blood.
To get the test, the blood must be analyzed for the COVID gene mutation in order to be able to test for it.
That’s why the Arkansas Blood Institute is working with the Institute for Human Genetics, which is working on a new test.
“We are hoping that the test will have some utility to help people who have these COVID mutations,” said Dr. Eric Schmader, director of the Arkansas Department of Health and Human Services.
“We think this test would be an effective tool to help us better understand how these people are reacting to COVID.”
The researchers say the new test is currently in testing in three states.
There are no plans to test blood in Arkansas, but a new study is expected to be published in December.
It is unclear what would happen if the test were to fail, which could be a serious problem for people with the mutation.
But the researchers say that it could help people whose health has been compromised by the mutation or to help others in the future.
This article is from the archive of our partner The Wire.